Toxic Interactions Of Romiplostim And Rituximab In Normal And Thrombocytopenic Rats
Journal Title: Journal of Applied Veterinary Sciences - Year 2020, Vol 5, Issue 1
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immunologic destruction of normal platelets and insufficient production of platelets mediated by autoantibodies. And there are different treatment options for management of thrombocytopenia according to each case. Because of the progression of the disease and its multiple pathophysiological pathways a combination of treatments used for management of ITP would be a point of interest. Co-administration of therapies may be useful in patients who are refractory to monotherapies and may result in a booster response because they target multiple mechanisms. Romiplostim is a potent drug used for the management of acute ITP and can be administered with other treatment options for ITP. The combination of Rituximab and Romiplostim may inhibit platelet destruction and at the same time increase platelet production. This combination can lead to a strong and a massive increase in platelet counts. In preclinical studies of Romiplostim safety margins could not be reliably estimated. Although some post marketing surveillance studies provided some information about the safety profile of this drug. More information is needed to evaluate drug interactions between Romiplostim and Rituximab.The goal of this study is to investigate the safety of co-treatment of Romiplostim with Rituximab as compared to each of these drugs in normal rats and thrombocytopenic rats. The measured safety parameters were evaluated for liver and kidney functions in normal and diseased groups of rats.The safety of this regimen should be taken in consideration, so that a balance between the harmful effects and beneficial response could be attained. Future studies are necessary to investigate the safety and efficacy balance of Romiplostim and Rituximab alone or in combination with each other for management of thrombocytopenia.
Authors and Affiliations
Saeed H. , Sayed H. M. , Ramadan A. , Nahla S. Kotb
Keywords
Related Articles
- EP ID EP679159
- DOI https://dx.doi.org/10.21608/javs.2019.20470.1000
- Views 196
- Downloads 1
Preparation of a Combined Inactivated Vaccine against Riemerella anatipestifer and Duck Viral Hepatitis
Riemerella anatipestifer (R. anatipestifer) infection and duck virus hepatitis (DVH) are enormous dangers for the duck industry and its investment. So, in the current study, a combined inactivated vaccine against both of...
Isolation and Identification of the most Common Bacteria Isolated from Intestine of Broiler Chickens in Egypt
Bacteria are seriously affecting broiler chickens and the poultry industry in many countries, as well as in Egypt. Both pathogenic and nonpathogenic bacterial species have been reported in broiler chickens. The present s...
Comparison Between Electroacupuncture, Detomidine Plus Electroacupuncture And Detomidine Alone For Laparoscopic Surgery In Goats
This study aimed to validate the effectiveness of electroacupuncture (EA), detomidine plus electroacupuncture and detomidine alone for laparoscopy in goats in terms of physiological variables, vital parameters, CBC and p...
Future Trend to Replace Chemical Products with Nutraceutical Food / Feed Additive: A Mini Review
Since thousands of years, herbal products were used for medical purposes in old cultures. The present trend to re-discover the medical potential of herbs started to grow with the general awareness of the medical hazards...
Isolation and characterization of stx1 and stx2 toxin-producing Escherichia coli in neonatal lambs with diarrhea in Nineveh governorate, Iraq
Escherichia coli causes many health problems in lambs, the most prominent of which is diarrhea, the study aimed to detect the shiga toxins genes in E.coli isolated from the suckling lambs affected with diarrhea in Nineve...